Omega-3, Metabolic Syndrome, and Schizophrenia: A review

Roudbaraki, Seyedeh Narjes and Behdani, Fatemeh and Hebrani, Paria and Ghayour-Mobarhan, Majid and Vahabi Amlashi, Sadegh (2017) Omega-3, Metabolic Syndrome, and Schizophrenia: A review. Journal of Patient Safety & Quality Improvement, 5 (1). pp. 502-504.

[img]
Preview
Text
PSJ_Volume 5_Issue 1_Pages 502-504.pdf

Download (456kB) | Preview
Official URL: http://psj.mums.ac.ir/article_8163.html

Abstract

According to the literature, schizophrenia is associated with the components of metabolic syndrome. This mental disorder has such manifestations as visceral obesity, impaired lipid metabolism, hyperglycemia, and hypertension. The prevalence rate of schizophrenia varies in different countries. There is a body of evidence about the higher incidence of cardiovascular events in the schizophrenic patients with metabolic syndrome. Therefore, the prevention or treatment of this condition in sthese patients is a matter of fundamental importance. Fish oils, commonly used by people, contain omega-3 fatty acid. Omega-3 has been demonstrated to be effective in the patients with metabolic syndrome.Â

Item Type: Article
Subjects: WD Nutrition Disease and metabolic diseases
Divisions: Journals > J Patient Safety & Quality improvement
Depositing User: psj psj
Date Deposited: 04 Sep 2017 14:26
Last Modified: 04 Sep 2017 14:26
URI: http://eprints.mums.ac.ir/id/eprint/445

Actions (login required)

View Item View Item